20 March, 2025Nitrase Therapeutics unveils protein with newly characterized enzymatic function involved in the pathogenesis of Parkinson’s Disease
20 March, 2025Sitryx initiates Phase 1 clinical trial of potential disease-modifying treatment for atopic dermatitis SYX-5219
18 March, 2025Sofinnova Partners exceeds target with €165M biotech acceleration fund, Europe’s largest, with strong Pharma support
10 March, 2025T-Therapeutics appoints Theodora Harold as Chief Executive Officer, reflecting Company’s ambitious growth plans and progression into therapeutic development